IC
CL icon

IEQ Capital’s Colgate-Palmolive CL Stock Holding History

IEQ Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$976K Buy
10,650
+6,793
+176% +$594K ﹤0.01% 1103
2026
Q1 		$329K Buy
3,857
+34
+0.9% +$3.03K ﹤0.01% 1481
2025
Q4 		$302K Buy
3,823
+813
+27% +$63.7K ﹤0.01% 1532
2025
Q3 		$241K Sell
3,010
-4,784
-61% -$408K ﹤0.01% 1614
2025
Q2 		$708K Buy
7,794
+3,181
+69% +$290K ﹤0.01% 987
2025
Q1 		$432K Sell
4,613
-53,395
-92% -$4.78M ﹤0.01% 1033
2024
Q4 		$5.27M Buy
58,008
+11,666
+25% +$1.11M 0.05% 259
2024
Q3 		$4.81M Buy
46,342
+7,725
+20% +$787K 0.06% 202
2024
Q2 		$3.75M Buy
38,617
+7,130
+23% +$658K 0.05% 223
2024
Q1 		$2.84M Buy
31,487
+1,419
+5% +$120K 0.04% 259
2023
Q4 		$2.4M Buy
30,068
+2,127
+8% +$160K 0.04% 261
2023
Q3 		$1.99M Sell
27,941
-2,916
-9% -$218K 0.04% 264
2023
Q2 		$2.38M Sell
30,857
-1,420
-4% -$110K 0.05% 238
2023
Q1 		$2.43M Buy
32,277
+9,354
+41% +$696K 0.06% 223
2022
Q4 		$1.81M Sell
22,923
-6,218
-21% -$466K 0.05% 258
2022
Q3 		$2.05M Buy
29,141
+12,371
+74% +$970K 0.06% 226
2022
Q2 		$1.34M Buy
16,770
+5,440
+48% +$425K 0.04% 259
2022
Q1 		$859K Sell
11,330
-511
-4% -$40.5K 0.02% 367
2021
Q4 		$1.01M Buy
11,841
+1,861
+19% +$145K 0.02% 305
2021
Q3 		$754K Buy
9,980
+2,622
+36% +$208K 0.02% 337
2021
Q2 		$599K Buy
7,358
+1,914
+35% +$157K 0.02% 318
2021
Q1 		$429K Buy
+5,444
New +$427K 0.02% 300
2020
Q4 		– Sell
-3,814
Closed -$294K – 250
2020
Q3 		$294K Buy
+3,814
New +$291K 0.02% 302
2020
Q2 		– Sell
-7,544
Closed -$501K – 336
2020
Q1 		$501K Buy
7,544
+166
+2% +$11.7K 0.04% 206
2019
Q4 		$508K Buy
+7,378
New +$503K 0.04% 217

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

IEQ Capital's CL Position: Q2 2026 in Review

IEQ Capital increased its Colgate-Palmolive (CL) stake by 176% in Q2 2026, buying an estimated $594K and bringing the position to 10,650 shares worth $976K. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

IEQ Capital first reported a position in CL in Q4 2019 and has held it in 25 quarters since. The position peaked at $5.27M in Q4 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • IEQ Capital held 10,650 shares of Colgate-Palmolive worth $976K as of Q2 2026.
  • IEQ Capital bought 6,793 Colgate-Palmolive shares in Q2 2026, an estimated $594K.
  • Colgate-Palmolive made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1103 holding.
  • IEQ Capital first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 25 quarters since.
  • IEQ Capital's Colgate-Palmolive position peaked at $5.27M in Q4 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.